Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

TD Bank, Boeing And Medicare: Compliance Headlines In 2024 No Photo Available

Corporate compliance lessons were never far from the headlines in 2024, as regulatory challenges and headaches facing industries rangi... (more story)

Top Government Contracts Of 2024: Year In Review No Photo Available

This year, the U.S. General Services Administration made dozens of awards for two massive, uncapped governmentwide deals, while the U.... (more story)

The Most Significant Trade Secrets Cases Of 2024 No Photo Available

Insulet Corp. became the latest company to notch a colossal trade secrets award, and a new presidential administration has attorneys w... (more story)